NVCR - NovoCure Ltd Price Target Chart

Corporate company logo of NovoCure Ltd (NVCR)

The price trend for NovoCure Limited (NVCR) reflects the dynamics of an asset valued at 22.89. The business relies on an autonomous demand cycle, remaining resilient to crises and macroeconomic pressure. NovoCure Limited (NVCR) creates synergy with pharmaceutical leaders to implement Tumor Treating Fields. While device production is automated, the final calibration of systems and medical supervision are performed manually by specialists.

NVCR novocure.com: Price Target Chart in the range 07/04/2022 - 11/15/2026

Analytical breakdowns for novocure.com (NVCR)

- stock price and consensus target price:
Share Price NovoCure Corp|NVCR - Consensus Target
- market capitalization statistics:
Market Value Novocure|NVCR - Enterprise Value
- issuer book value statistics:
Accounting Value per Share NovoCure|NVCR - Company Book Value|Market Value to Book Value novocure.com|NVCR - Aggregate Company Assets
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio NovoCure Limited|NVCR - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient novocure.com|NVCR - Company Debts|Debts to Net Assets Novocure|NVCR - Company Long-Term Debts|Company Current Liabilities NovoCure|Immediate Liquidity novocure.com
- business earnings and investment ratios data:
NVCR - Company Net Income|Expected Profit NovoCure Limited|NVCR - Price to Earnings Ratio|Future Price to Earnings NovoCure Corp|NVCR - PEG Multiple|EV/EBITDA Multiple NovoCure|NVCR - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months NovoCure|NVCR - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months novocure.com|NVCR - Earnings per share growth in current year|Expected net earnings per share growth next year NovoCure Limited
- total revenue and sales volume data:
NVCR - Company Sales|Projected Sales Volume NovoCure Ltd|NVCR - Price-to-Revenue Ratio|Market Cap to Expected Sales Ratio NovoCure Limited
Fundamental company analysis:NVCR, NovoCure
Original product of NovoCure Limited

This indicator represents the weighted average of target prices from leading analysts, determining the asset's fundamental fair value. The calculation model is sensitive to cash flow revisions following the publication of quarterly reports. The consensus forecast price action filters out market noise, revealing the true vector of capitalization. For NovoCure Limited (NVCR), this metric reflects market expectations regarding the scaling of TTFields system sales. An increasing target confirms the expansion of this innovative cancer therapy.

Competing companies

Alpha Tau Medical Ltd - Broker Consensus Forecast|Analyst Consensus Forecast FBIO (Fortress)|ACRV - Consensus Target|ALLR - Price Target Chart